ClinicalTrials.gg

What’s New Sign In

Biological

GP-100 antigen clinical trials

Also written gp100 antigen and gp 100.

studies test it: 30
open now: 0
in phase 3: 2
first study started: 1995

How studies write it

Studies that test it under each name

Development codes

gp 100: 2

Other names

gp100 antigen: 25

Combined with it in one product

gp100:209-217: 1
MDX-1379 (gp100) Melanoma Peptide Vaccine: 1
melanoma peptide vaccine: 1
gp100 human melanoma peptide: 1
GP100 peptide: 1

Studies by the year they started

30 studies that test it; most in 1999 (7)

By phase

A phase 1/2 study counts in both.

Phase 1: 10
Phase 2: 20
Phase 3: 2

What it is tested for

Each study’s main condition, where its own words name it.

Melanoma: 29
Uveal Melanoma: 1

Who runs them

Industry 2 · Other 28

National Cancer Institute (NCI) (15) · University of Southern California (6) · University of Wisconsin, Madison (1) · Mayo Clinic (1) · University of Illinois at Chicago (1) · Providence Cancer Center, Earle A. Chiles Research Institute (1) · National Institutes of Health Clinical Center (CC) (1) · Eastern Cooperative Oncology Group (1)

Often tested with

Tested in the same studies.

MART-1 Antigen (12) · Interleukin-2 (4) · Melanocyte Protein PMEL (4) · Sargramostim (2) · Interleukin-12 (2) · Tyrosinase Peptide (2) · Incomplete Freund's adjuvant (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1)

Studies

Open first, then newest update. How each study uses GP-100 antigen is read from its arms, and is right about nine times in ten.

Testing it · 30

See all 30 studies that test GP-100 antigen →

Given in every arm · 7 — GP-100 antigen is usual care beside what is tested

Codes

What other systems call GP-100 antigen · ClinicalTrials.gg INT014334

UNII (FDA) 1NU720978FGP-100 ANTIGENOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	1NU720978F	GP-100 ANTIGEN	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.